Control Bionics Limited (ASX:CBL)

Australia flag Australia · Delayed Price · Currency is AUD
0.0390
-0.0010 (-2.50%)
Aug 29, 2025, 12:57 PM AEST
-2.50%
Market Cap11.49M
Revenue (ttm)7.04M
Net Income (ttm)-6.11M
Shares Out294.61M
EPS (ttm)-0.02
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume26,995
Average Volume72,978
Open0.0400
Previous Close0.0400
Day's Range0.0390 - 0.0400
52-Week Range0.0260 - 0.0960
Beta0.02
RSI48.41
Earnings DateAug 22, 2025

About Control Bionics

Control Bionics Limited, together with its subsidiaries, engages in the research, development, commercialization, and sale of assistive communications technology systems in Australia, North America, and internationally. The company offers NeuroNode Trilogy, NeuroNode Duo, and Eye-gaze Duo systems that allow people with speech and movement difficulties to control a computer for speech generation, electronic communications, entertainment, and external control of other devices. It also provides Cosmos Connect, a small portable control device that ... [Read more]

Sector Healthcare
Founded 2005
Country Australia
Stock Exchange Australian Securities Exchange
Ticker Symbol CBL
Full Company Profile

Financial Performance

In 2024, Control Bionics's revenue was 5.35 million, a decrease of -5.17% compared to the previous year's 5.64 million. Losses were -5.91 million, 5.02% more than in 2023.

Financial Statements

News

There is no news available yet.